CmaxInsight Market Intelligence: Market Research Reports

... clients within 1-2 Business Days. CmaxInsight’s, “SRC Family Kinases (SFK) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence SRC Family Kinases (SFK) Inhibitor R&D Please note: Certain sections in the ...

... coverage of MoA enables the client to understand the landscape of the Sterol 14 Alpha-Demethylase Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

... Days. CmaxInsight’s, “Superoxide Dismutase (SOD) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Superoxide Dismutase (SOD) Inhibitor. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “T Cell Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the T Cell Inhibitor. Pipeline Covered: This section mentions all the promising therapies in ...

... within 1-2 Business Days. CmaxInsight’s, “Tau Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Tau Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

... within 1-2 Business Days. CmaxInsight’s, “Telomerase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the Telomerase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... Days. CmaxInsight’s, “Tetrahydrofolate Dehydrogenase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Tetrahydrofolate Dehydrogenase Inhibitor. Pipeline Covered: This section mentions all the ...

... within 1-2 Business Days. CmaxInsight’s, “TGF-Beta Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the TGF-Beta Inhibitor. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “TGF-Beta-1 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the TGF-Beta-1 Inhibitor. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Tie-2 modulators-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Tie-2 modulators. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Tie-2 Receptor Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Tie-2 Receptor Inhibitor. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “TIM-3 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the TIM-3 Antagonist. Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “Toll- Like Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Toll- Like Receptor Agonist. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “Toll-Like Receptor 4 (TLR-4) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Toll-Like Receptor 4 (TLR-4) Agonist R&D Please note: Certain sections in the ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Toll-Like Receptor 7, 8 (TLR-8) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Toll-Like Receptor 7, 8 (TLR-8) Agonist to enhance and expand business potential ...

... clients within 1-2 Business Days. CmaxInsight’s, “Toll-Like Receptor 9 (TLR-9) Modulator-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Toll-Like Receptor 9 (TLR-9) Modulator R&D Please note: Certain sections in the ...

... Business Days. CmaxInsight’s, “Toll-Like Receptor Modulators-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Toll-Like Receptor Modulators. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Topoisomerase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Topoisomerase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... to the clients within 1-2 Business Days. CmaxInsight’s, “TRAIL Receptor 1 & Receptor 2 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... by identifying potential partners with progressing projects for TRAIL Receptor 1 & Receptor 2 Agonist to enhance and expand business potential ...

... clients within 1-2 Business Days. CmaxInsight’s, “Transforming Growth Factor (TGF) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence Transforming Growth Factor (TGF) Inhibitor R&D Please note: Certain sections in the ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Transforming Growth Factor Beta (TGFb) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Transforming Growth Factor Beta (TGFb) Inhibitor to enhance and expand business ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist-Pipeline ... leading companies Assess challenges and opportunities that influence Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist-Pipeline ... leading companies Assess challenges and opportunities that influence Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist ...

... can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ...

... can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ...

... the clients within 1-2 Business Days. CmaxInsight’s, “TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonist ... identifying potential partners with progressing projects for TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Tumor Necrosis Factor Alpha (TNF-a) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Tumor Necrosis Factor Alpha (TNF-a) Agonist to enhance and expand business potential ...

... to the clients within 1-2 Business Days. CmaxInsight’s, “Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitor-Pipeline Intelligence, 2019”, report provides ... identifying potential partners with progressing projects for Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitor to enhance and expand ...

... coverage of MoA enables the client to understand the landscape of the Ubiquitin conjugating enzyme Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

... clients within 1-2 Business Days. CmaxInsight’s, “Ubiquitin Specific Proteases (USP) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence Ubiquitin Specific Proteases (USP) Inhibitor R&D Please note: Certain sections in the ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Vascular Adhesion Protein 1 (VAP-1) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Vascular Adhesion Protein 1 (VAP-1) Inhibitor to enhance and expand business ...

... clients within 1-2 Business Days. CmaxInsight’s, “Vascular Endothelial Growth Factor Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence Vascular Endothelial Growth Factor Inhibitor R&D Please note: Certain sections in the ...

... to the clients within 1-2 Business Days. CmaxInsight’s, “Vascular Endothelial Growth Factor A (VEGF-A) Inhibitor-Pipeline Intelligence, 2019”, report provides ... by identifying potential partners with progressing projects for Vascular Endothelial Growth Factor A (VEGF-A) Inhibitor to enhance and expand ...

... Business Days. CmaxInsight’s, “Vasopressin Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Vasopressin Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “Vasopressin V1 Receptor (V1R) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Vasopressin V1 Receptor (V1R) Antagonist R&D Please note: Certain sections in the ...

... clients within 1-2 Business Days. CmaxInsight’s, “Vasopressin V2 Receptor (V2R) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Vasopressin V2 Receptor (V2R) Agonist R&D Please note: Certain sections in the ...

... clients within 1-2 Business Days. CmaxInsight’s, “Vasopressin V2 Receptor (V2R) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Vasopressin V2 Receptor (V2R) Antagonist R&D Please note: Certain sections in the ...

... clients within 1-2 Business Days. CmaxInsight’s, “VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor-Pipeline Intelligence, 2019”, report ... potential partners with progressing projects for VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor to enhance and ...

... Business Days. CmaxInsight’s, “Viral RNA Polymerase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Viral RNA Polymerase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive ... potential partners with progressing projects for Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist to enhance and expand business ...

... coverage of MoA enables the client to understand the landscape of the Voltage-Dependent Calcium Channel Blockers. Pipeline Covered: This section mentions all the promising therapies in different ...

... within 1-2 Business Days. CmaxInsight’s, “Voltage-Dependent T-Type Calcium Channel Blockers-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Voltage-Dependent T-Type Calcium Channel Blockers R&D Please note: Certain sections in ...

... coverage of MoA enables the client to understand the landscape of the Voltage-Gated Sodium Channel Blockers. Pipeline Covered: This section mentions all the promising therapies in different ...

... Days. CmaxInsight’s, “Wnt Signaling Pathway Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Wnt Signaling Pathway Inhibitor. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Xanthine Oxidase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Xanthine Oxidase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Factor VIII Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Factor VIII Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...